A novel Fc-optimized antibody drug conjugate targeting CD7 as a therapeutic strategy in T-cell acute lymphoblastic leukemia

enthalten in: Blood | 2023

von Gehlert, C. | Schewe, D. | Klausz, K. | +18

Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia : long-term clinical and MRD results of the German CLL Study Group CLL3X trial

enthalten in: Blood | 2010

von Dreger, P. | Döhner, H. | Ritgen, M. | +43

Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial

enthalten in: Blood | 2010

von Dreger, P. | Döhner, H. | Ritgen, M. | +20

Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia : long-term clinical and MRD results of the German CLL Study Group CLL3X trial

enthalten in: Blood | July 1, 2010

von Dreger, P. | Döhner, H. | Ritgen, M. | +20

Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status : implications of minimal residual disease measurement with quantitative PCR

enthalten in: Blood | 2004

von Ritgen, M. | Stilgenbauer, S. | von Neuhoff, N. | +11